DF

Daniel Franke

Investment Director at M Ventures

Greater Boston

Overview 

Daniel Franke is an Investment Director at M Ventures, specializing in technology investments in sectors such as Semiconductors, DeepTech, and BioTech. With a Ph.D. from MIT and experience serving on the boards of companies like Polaris Electro-Optics and Sonde Health, he has successfully led investments in impactful startups like Polaris Electro-Optics at various stages, showcasing his expertise in the field.

Work Experience 

  • Investment Director, Technology Investments

    2018 - Current

  • Board Observer

    2024

Thintronics is a Consumer Electronics company.

Raised $23,000,000.00 from TGVP, M Ventures, Tallwood Venture Capital, Maverick Capital and Translink Capital.

  • Board Observer

    2023

  • Board Director

    2022

Polaris Electro-Optics empowers integrated photonics for communications and computation.

Raised $3,000,000.00 from M Ventures, Buff Gold Ventures and Rhapsody Venture Partners.

  • Board Observer

    2021

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

Raised $254,251,237.00 from Niterra Ventures, Taisho Pharmaceutical Holdings, Features Capital, Aphelion Capital, Alpha Wave Ventures, Global Health Investment Corporation, Senvest Management, AXA Investment Managers, Pegasus Tech Ventures and RiverVest.

  • Board Director

    2021

  • Board Observer

    2021

SeeQC is a semiconductor company developing commercially viable application-specific quantum computing systems for global businesses.

Raised $38,649,473.00 from US Department of Energy and Innovate UK.

  • Board Director

    2020

MemryX is an AI chip startup developing an innovative Edge AI Accelerator.

  • Board Observer

    2020

Metalenz designs and sells metasurface optics for sensing in consumer electronics and automotive markets.

Raised $47,360,746.00 from Braemar Ventures, Foothill Ventures, Neotribe Ventures, Global Brain Corporation, SGInnovate, TDK Ventures, OUP (Osage University Partners), Hegemon Capital, Intel Capital and 3M New Ventures.

  • Board Director

    2019

Neurable is a neurotechnology company focused on developing AI tools for brain signal translation and brain-computer interface technology.

Raised $22,756,543.00 from Pace Ventures, TRAC, Metaplanet, Ultratech Capital Partners and TRAC.

Articles About Daniel

Relevant Websites